Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Bifunctional ligands that target cells displaying the alpha v beta3 integrin.

Bifunctional ligands that target cells displaying the alpha v beta3 integrin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Bifunctional ligands that target cells displaying the alpha v beta3 integrin. Abstract Text:

    robert m owenRobert M Owen,coby b carlsonCoby B Carlson,jinwang xuJinwang Xu,patricia moweryPatricia Mowery,elisabetta fasellaElisabetta Fasella,laura l kiesslingLaura L Kiessling,

    Strategies to eliminate tumor cells have long been sought. We envisioned that a small molecule could be used to decorate the offending cells with immunogenic carbohydrates and evoke an immune response. To this end, we describe the synthesis of bifunctional ligands possessing two functional motifs: one binds a cell-surface protein and the other binds a naturally occurring human antibody. Our conjugates combine an RGD-based peptidomimetic, to target cells displaying the alpha v beta3 integrin, with the carbohydrate antigen galactosyl-alpha(1-3)galactose [Galalpha(1-3)Gal or alpha-Gal]. To generate such bifunctional ligands, we designed and synthesized RGD mimetics 1 b and 2 c, which possess a free amino group for modification. These compounds were used to generate bifunctional derivatives 1 c and 2 d, with dimethyl squarate serving as the linchpin; thus, our synthetic approach is modular. To evaluate the binding of our peptidomimetics to the target alpha v beta3-displaying cells, we implemented a cell-adhesion assay. Results from this assay indicate that the designed, small-molecule ligands inhibit alpha v beta3-dependent cell adhesion. Additionally, our most effective bifunctional ligand exhibits a high degree of selectivity (4000-fold) for alpha v beta3 over the related alpha v beta5 integrin, a result that augurs its utility in specific cell targeting. Finally, we demonstrate that the bifunctional ligands can bind to alpha v beta3-positive cells and recruit human anti-Gal antibodies. These results indicate that both the integrin-binding and the anti-Gal-binding moieties can act simultaneously. Bifunctional conjugates of this type can facilitate the development of new methods for targeting cancer cells by exploiting endogenous antibodies. We anticipate that our modifiable alpha v beta3-binding ligands will be valuable in a variety of applications, including drug delivery and tumor targeting.

    Bifunctional ligands that target cells displaying the alpha v beta3 integrin. Publishing Authors By Initials

    rm owenRM Owen,cb carlsonCB Carlson,j xuJ Xu,p moweryP Mowery,e fasellaE Fasella,ll kiesslingLL Kiessling,

    For similar biochemical phenomena, metabolism, and nutrition: biochemical phenomena: structure-activity relationship research abstracts see: biochemical phenomena, metabolism, and nutrition: biochemical phenomena: structure-activity relationship research

    PUBMED ID PMID:

    MEDLINE DATE:

    Bifunctional ligands that target cells displaying the alpha v beta3 integrin. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Chembiochem : a European journal of chemical biolo

    VOLUME: 8

    Page Numbers: 68-82

    Journal Abbreviation: Chembiochem

    ISSN: 1439-4227

    DAY: 2

    MONTH: Jan

    YEAR: 2007

    Bifunctional ligands that target cells displaying the alpha v beta3 integrin. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100937360

    Bifunctional ligands that target cells displaying the alpha v beta3 integrin. Keywords Mesh Terms:

    KEYWORDS: Structure-Activity Relationship

    MESH TERMS: chemistry

    Chemical & Substance for Abstract: Bifunctional ligands that target cells displaying the alpha v beta3 integrin. Information

    Substance Name: arginyl-glycyl-aspartic acid

    Registry Number: 99896-85-2

    Grant and Affiliation Information for Bifunctional ligands that target cells displaying the alpha v beta3 integrin.

    AFFILIATION: Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY: United States NIGMS

    GRANT: GM07215

    ACRONYM: GM

    MEDLINETA: Chembiochem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Bifunctional ligands that target cells displaying the alpha v beta3 integrin Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News